A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: trouble (31), riot (2), disorder (273)

Docetaxel (75)-Prednisolone ver1.2

Description
Chemotherapy Protocol PROSTATE DOCETAXEL(75)-PREDNISOLONE Regimen Prostate-Docetaxel (75)-Prednisolone Indication Advanced castrate resistant prostate cancer Performance status 0, 1
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Docetaxel-75-Prednisolone-ver1.2.pdf

Docetaxel (75) Prednisolone (6 cycles)) Ver1

Description
Chemotherapy Protocol PROSTATE DOCETAXEL(75)-PREDNISOLONE (6 cycles) Regimen Prostate-Docetaxel (75)-Prednisolone (6 cycles) Indication First line treatment of prostate
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Docetaxel-75-Prednisolone-6-cycles-Ver1.pdf

Cabazitaxel-Prednisolone

Description
Chemotherapy Protocol PROSTATE CABAZITAXEL-PREDNISOLONE Regimen • Prostate-Cabazitaxel-Prednisolone Indication • Castrate resistant metastatic prostate cancer previously treated with docetaxel containing regimens
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Cabazitaxel-Prednisolone.pdf

Cabozantinib

Description
Chemotherapy Protocol RENAL CELL CANCER Regimen CABOZANTINIB • Renal Cell – Cabozantinib (60mg-tablets) Indication • Cabozantinib s indicated for the treatment of advanced
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Cabozantinib.pdf

GDP-Cisplatin-Dexamethasone-Gemcitabine

Description
Chemotherapy Protocol LYMPHOMA CISPLATIN-DEXAMETHASONE-GEMCITABINE (GDP) Regimen • Lymphoma – GDP-Cisplatin-Dexamethasone-Gemcitabine Indication • Hodgkin’s Lymphoma Toxicity Drug Cisplatin Dexamethasone
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/GDP-Cisplatin-Dexamethasone-Gemcitabine.pdf

FC IV (3 day)-Cyclophosphamide-Fludarabine IV (3 day) Ver 1.1

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE–FLUDARABINE INTRAVENOUS (FC IV 3 day) Regimen Lymphoma – FC IV (3 day)- Cyclophosphamide-Fludarabine IV (3 day
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/FC-IV-3-day-Cyclophosphamide-Fludarabine-IV-3-day-Ver-1.1.pdf

Z-DEX dexamethasone idarubicin ver1

Description
Chemotherapy Protocol MULTIPLE MYELOMA Z-DEX-DEXAMETHASONE-IDARUBICIN Regimen Multiple Myeloma – Z-DEX-Dexamethasone-Idarubicin Indication First or subsequent line treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Z-DEX-dexamethasone-idarubicin-ver1.pdf

Dabrafenib Trametinib Ver1

Description
Chemotherapy Protocol SKIN CANCER DABRAFENIB-TRAMETINIB Regimen  Skin – Dabrafenib-Trametinib Indication  The combination of dabrafenib and trametinib is recommended as an
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinDabrafenibTrametinibVer1.pdf

Thyroid Cabozantinib

Description
Chemotherapy Protocol THYROID CANCER Regimen CABOZANTINIB • Thyroid – Cabozantinib (140mg-capsules) Indication • Unresectable, locally advanced or metastatic thyroid cancer where the disease
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Thyroid-Cabozantinib.pdf

Carboplatin (AUC5) -Pegylated Liposomal Doxorubicin Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5) – PEGYLATED LIPOSOMAL DOXORUBICIN (Caelyx) Retreat Please note this protocol is based on information for the
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Carboplatin-AUC5-Pegylated-Liposomal-Doxorubicin-Retreat-Caelyx.pdf
81 to 90 of 282
Previous … 7 8 9 10 11 … Next